Premium Reports
PACS - Ambulatory/Imaging Center Report 2005

PACS - Ambulatory/Imaging Center Report 2005

November 22, 2005

Current Time Inside Cache Tag Helper: 4/14/2021 1:02:51 PM and Model.reportId = 284

The PACS Ambulatory/Imaging Center Report focuses on PACS vendors and systems in free-standing imaging centers.

Healthcare Providers,
Want to see more reports?

Not a Provider, contact us for pricing details.

HtmlReportContent Current Time Inside Cache Tag Helper: 4/14/2021 1:02:51 PM and Model.reportId= 284 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637406508813452487

The report compares the strengths and weaknesses of today's ambulatory/imaging center PACS vendors against one another, against all ambulatory/imaging center PACS vendors and against the KLAS HIT average.

Eight Ambulatory PACS vendor products are featured in this report: AMICAS Vision Series, DR Systems Dominator, Dynamic Imaging IntegradWeb, Fuji Synapse, Intelerad IntelePACS, Merge eMed Fusion, NovaRad PACS, and RamSoft PowerServer.

In addition an Early Data section features vendors whose products have not yet met KLAS' minimum confidence level in order to be compared with the vendors in the main body of the report. These vendors include Agfa Impax, BRIT Systems, McKesson Horizon Medical Imaging, Merge eMed Matrix, Philips EasyAccess, Philips iSite (Stentor), ScImage PicomEnterprise, Sectra PACS Enterprise Edition, and StorCOMM AccessNET PACS.

An Addendum contains one vendor, Medweb, for which KLAS has no data, however, a vendor overview was provided.

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.